Global Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06251682

Publication Date:

June 27, 2025

Pages:

153

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pharmaceutical Outsourcing Services (CXO) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Lonza Pharmaceuticals
Thermo Fisher
Caterent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Notai Biotech
Jiuzhou Pharmaceutical
Kai Laiying
Medici
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract production services (CDMOCMO). In the process of new drug R&D, through pharmaceutical contract outsourcing, pharmaceutical companies or biotechnology companies entrust drug R&D and production companies to provide professional R&D services, including the development of technical processes required for the production of drugs, the production of APIs and intermediates, and preparation production.
United States market for Pharmaceutical Outsourcing Services (CXO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pharmaceutical Outsourcing Services (CXO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pharmaceutical Outsourcing Services (CXO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pharmaceutical Outsourcing Services (CXO) players cover Lonza Pharmaceuticals, Thermo Fisher, Caterent, Jubilant LifeSciences, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧harmaceutical Outsourcing Services (CXO) Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Outsourcing Services (CXO) sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Outsourcing Services (CXO) sales for 2025 through 2031. With Pharmaceutical Outsourcing Services (CXO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Outsourcing Services (CXO) industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Outsourcing Services (CXO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Outsourcing Services (CXO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Outsourcing Services (CXO) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Outsourcing Services (CXO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Outsourcing Services (CXO).
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Outsourcing Services (CXO) market by product type, application, key players and key regions and countries.
Segmentation by Type:
CRO
CMO/CDMO
CSO
Segmentation by Application:
Clinical Stage Projects
Commercialization Stage Projects
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza Pharmaceuticals
Thermo Fisher
Caterent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
IQVIA
Labcorp Drug Development
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Notai Biotech
Jiuzhou Pharmaceutical
Asymchem Laboratories (Tianjin) Co., Ltd.
Shanghai Medicilon Inc.
ChemPartner
AmbioPharm
CordenPharma

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size (2020-2031)
2.1.2 Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical Outsourcing Services (CXO) by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical Outsourcing Services (CXO) Segment by Type
2.2.1 CRO
2.2.2 CMO/CDMO
2.2.3 CSO
2.3 Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Type
2.3.1 Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Pharmaceutical Outsourcing Services (CXO) Segment by Application
2.4.1 Clinical Stage Projects
2.4.2 Commercialization Stage Projects
2.5 Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Application
2.5.1 Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Player
3.1 Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pharmaceutical Outsourcing Services (CXO) Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical Outsourcing Services (CXO) Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Pharmaceutical Outsourcing Services (CXO) Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Outsourcing Services (CXO) by Region
4.1 Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Region (2020-2025)
4.2 Global Pharmaceutical Outsourcing Services (CXO) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size Growth (2020-2025)
4.4 APAC Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size Growth (2020-2025)
4.5 Europe Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Country (2020-2025)
5.2 Americas Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Type (2020-2025)
5.3 Americas Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Region (2020-2025)
6.2 APAC Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Type (2020-2025)
6.3 APAC Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Country (2020-2025)
7.2 Europe Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Type (2020-2025)
7.3 Europe Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Forecast
10.1 Global Pharmaceutical Outsourcing Services (CXO) Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical Outsourcing Services (CXO) Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical Outsourcing Services (CXO) Forecast
10.1.3 APAC Pharmaceutical Outsourcing Services (CXO) Forecast
10.1.4 Europe Pharmaceutical Outsourcing Services (CXO) Forecast
10.1.5 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Forecast
10.2 Americas Pharmaceutical Outsourcing Services (CXO) Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.2.2 Canada 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.2.3 Mexico 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.2.4 Brazil 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.3 APAC Pharmaceutical Outsourcing Services (CXO) Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical Outsourcing Services (CXO) 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.3.3 Korea 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.3.4 Southeast Asia 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.3.5 India 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.3.6 Australia 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.4 Europe Pharmaceutical Outsourcing Services (CXO) Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.4.2 France 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.4.3 UK 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.4.4 Italy 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.4.5 Russia 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.5 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.5.2 South Africa 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.5.3 Israel 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.5.4 Turkey 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
10.6 Global Pharmaceutical Outsourcing Services (CXO) Forecast by Type (2026-2031)
10.7 Global Pharmaceutical Outsourcing Services (CXO) Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Pharmaceutical Outsourcing Services (CXO) Forecast
11 Key Players Analysis
11.1 Lonza Pharmaceuticals
11.1.1 Lonza Pharmaceuticals Company Information
11.1.2 Lonza Pharmaceuticals Pharmaceutical Outsourcing Services (CXO) Product Offered
11.1.3 Lonza Pharmaceuticals Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Lonza Pharmaceuticals Main Business Overview
11.1.5 Lonza Pharmaceuticals Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Pharmaceutical Outsourcing Services (CXO) Product Offered
11.2.3 Thermo Fisher Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 Caterent
11.3.1 Caterent Company Information
11.3.2 Caterent Pharmaceutical Outsourcing Services (CXO) Product Offered
11.3.3 Caterent Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Caterent Main Business Overview
11.3.5 Caterent Latest Developments
11.4 Jubilant LifeSciences
11.4.1 Jubilant LifeSciences Company Information
11.4.2 Jubilant LifeSciences Pharmaceutical Outsourcing Services (CXO) Product Offered
11.4.3 Jubilant LifeSciences Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Jubilant LifeSciences Main Business Overview
11.4.5 Jubilant LifeSciences Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Pharmaceutical Outsourcing Services (CXO) Product Offered
11.5.3 Boehringer Ingelheim Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Information
11.6.2 Oxford BioMedica Pharmaceutical Outsourcing Services (CXO) Product Offered
11.6.3 Oxford BioMedica Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Oxford BioMedica Main Business Overview
11.6.5 Oxford BioMedica Latest Developments
11.7 Charles River
11.7.1 Charles River Company Information
11.7.2 Charles River Pharmaceutical Outsourcing Services (CXO) Product Offered
11.7.3 Charles River Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Charles River Main Business Overview
11.7.5 Charles River Latest Developments
11.8 IQVIA
11.8.1 IQVIA Company Information
11.8.2 IQVIA Pharmaceutical Outsourcing Services (CXO) Product Offered
11.8.3 IQVIA Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 IQVIA Main Business Overview
11.8.5 IQVIA Latest Developments
11.9 Labcorp Drug Development
11.9.1 Labcorp Drug Development Company Information
11.9.2 Labcorp Drug Development Pharmaceutical Outsourcing Services (CXO) Product Offered
11.9.3 Labcorp Drug Development Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Labcorp Drug Development Main Business Overview
11.9.5 Labcorp Drug Development Latest Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Information
11.10.2 WuXi AppTec Pharmaceutical Outsourcing Services (CXO) Product Offered
11.10.3 WuXi AppTec Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 WuXi AppTec Main Business Overview
11.10.5 WuXi AppTec Latest Developments
11.11 He Yuan Biology
11.11.1 He Yuan Biology Company Information
11.11.2 He Yuan Biology Pharmaceutical Outsourcing Services (CXO) Product Offered
11.11.3 He Yuan Biology Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 He Yuan Biology Main Business Overview
11.11.5 He Yuan Biology Latest Developments
11.12 GenScript Biotech
11.12.1 GenScript Biotech Company Information
11.12.2 GenScript Biotech Pharmaceutical Outsourcing Services (CXO) Product Offered
11.12.3 GenScript Biotech Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 GenScript Biotech Main Business Overview
11.12.5 GenScript Biotech Latest Developments
11.13 Kanglong Chemical
11.13.1 Kanglong Chemical Company Information
11.13.2 Kanglong Chemical Pharmaceutical Outsourcing Services (CXO) Product Offered
11.13.3 Kanglong Chemical Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Kanglong Chemical Main Business Overview
11.13.5 Kanglong Chemical Latest Developments
11.14 Porton shares
11.14.1 Porton shares Company Information
11.14.2 Porton shares Pharmaceutical Outsourcing Services (CXO) Product Offered
11.14.3 Porton shares Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Porton shares Main Business Overview
11.14.5 Porton shares Latest Developments
11.15 Notai Biotech
11.15.1 Notai Biotech Company Information
11.15.2 Notai Biotech Pharmaceutical Outsourcing Services (CXO) Product Offered
11.15.3 Notai Biotech Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Notai Biotech Main Business Overview
11.15.5 Notai Biotech Latest Developments
11.16 Jiuzhou Pharmaceutical
11.16.1 Jiuzhou Pharmaceutical Company Information
11.16.2 Jiuzhou Pharmaceutical Pharmaceutical Outsourcing Services (CXO) Product Offered
11.16.3 Jiuzhou Pharmaceutical Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Jiuzhou Pharmaceutical Main Business Overview
11.16.5 Jiuzhou Pharmaceutical Latest Developments
11.17 Asymchem Laboratories (Tianjin) Co., Ltd.
11.17.1 Asymchem Laboratories (Tianjin) Co., Ltd. Company Information
11.17.2 Asymchem Laboratories (Tianjin) Co., Ltd. Pharmaceutical Outsourcing Services (CXO) Product Offered
11.17.3 Asymchem Laboratories (Tianjin) Co., Ltd. Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Asymchem Laboratories (Tianjin) Co., Ltd. Main Business Overview
11.17.5 Asymchem Laboratories (Tianjin) Co., Ltd. Latest Developments
11.18 Shanghai Medicilon Inc.
11.18.1 Shanghai Medicilon Inc. Company Information
11.18.2 Shanghai Medicilon Inc. Pharmaceutical Outsourcing Services (CXO) Product Offered
11.18.3 Shanghai Medicilon Inc. Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Shanghai Medicilon Inc. Main Business Overview
11.18.5 Shanghai Medicilon Inc. Latest Developments
11.19 ChemPartner
11.19.1 ChemPartner Company Information
11.19.2 ChemPartner Pharmaceutical Outsourcing Services (CXO) Product Offered
11.19.3 ChemPartner Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 ChemPartner Main Business Overview
11.19.5 ChemPartner Latest Developments
11.20 AmbioPharm
11.20.1 AmbioPharm Company Information
11.20.2 AmbioPharm Pharmaceutical Outsourcing Services (CXO) Product Offered
11.20.3 AmbioPharm Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 AmbioPharm Main Business Overview
11.20.5 AmbioPharm Latest Developments
11.21 CordenPharma
11.21.1 CordenPharma Company Information
11.21.2 CordenPharma Pharmaceutical Outsourcing Services (CXO) Product Offered
11.21.3 CordenPharma Pharmaceutical Outsourcing Services (CXO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 CordenPharma Main Business Overview
11.21.5 CordenPharma Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.